Previous 10 | Next 10 |
SAN CARLOS, Calif. , Sept. 4, 2019 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced it will webcast a live presentation at the Morgan Stanley 17th Annual Global Healthcare Conference at the Grand Hyatt New York on Wednesday, Se...
SAN CARLOS, Calif. , Aug. 29, 2019 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, has appointed Rowan Chapman , Ph.D., to its board of directors, effective August 15, 2019 . "We are extremely pleased to welcome Dr. Rowan Chapman ...
SAN CARLOS, Calif. , Aug. 28, 2019 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced it will webcast a live presentation at the Baird 2019 Global Healthcare Conference at the InterContinental New York Barclay hotel in New York...
SAN CARLOS, Calif. , Aug. 22, 2019 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced that the Palmetto MolDX program has proposed a local coverage determination (LCD) for use of Natera's Signatera molecular resi...
SAN CARLOS, Calif. , Aug. 22, 2019 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA) , a global leader in cell-free DNA testing, today announced that it has now processed more than two million Panorama ® non-invasive prenatal tests (NIPT). Approximately 2,000 Panoram...
The following slide deck was published by Natera, Inc. in conjunction with their 2019 Q2 earnings Read more ...
Natera, Inc. (NTRA) Q2 2019 Earnings Conference Call August 7, 2019 4:30 PM ET Company Participants Michael Brophy – Chief Financial Officer Steve Chapman – Chief Executive Officer Paul Billings – Chief Medical Officer Solomon Moshkevich – General Ma...
Natera (NASDAQ: NTRA ): Q2 GAAP EPS of -$0.48 beats by $0.10 . More news on: Natera, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
SAN CARLOS, Calif. , Aug. 7, 2019 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a leader in non-invasive genetic testing and the analysis of circulating cell-free DNA, today reported financial results for its second quarter ended June 30, 2019 and provided an update on recen...
AAOI , AGO , AIG , ALB , AMPH , ANGI , ARNA , ASRT , ATO , AVLR , AZPN , BKNG , BREW , CABO , CAI , CCMP , CDE , CECO , CLI , COLL , CPA , CPRX , CSGS , CTL , CVNA , CWH , DAR , DOX , DVAX , EB , ECPG , ENS , ENV , ET , EVRG , FG , FLO , FNV , FOSL , ...
News, Short Squeeze, Breakout and More Instantly...
Study reports high accuracy of Signatera for surveillance of MCC patients, suggests potential to reduce frequency of surveillance imaging Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced a new study published in the Journal of Clinical Oncolog...
2024-07-23 12:58:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-13 10:12:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...